Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
This is where the GLP-1 or semaglutide drugs come into play
It works through growth hormone pathways, not sex hormone production
antigen affinity purified), streptavidin-HRP conjugate (4800-30-06), and tetramethyl benzidine (TMB) substrate solution (DY999) were purchased from R&D systems
This protocol uses lower initial doses of compounded semaglutide designed to reduce nausea and other side effects while still engaging your appetite-regulation pathways
-1775582746855.png&w=3840&q=75)
Other research highlights: 30% of GLP-1 users tested positive for SIBO or IMO even after accounting for diabetes (5) GLP-1 medicines caused microbiome changes and altered metabolism in mice (6) GLP-1 medicines tested in humans only had noticeable microbiome changes by 48 weeks (7) Despite not necessarily having slower gut motility, one study found that 88.9% of obese patients had SIBO (8) A meta analysis of people with IBS symptoms, found that up to 78% of people had SIBO, many of whom were undiagnosed (9) Overall, Sun and colleagues (1) could not prove a mechanistic link between GLP-1 medications and SIBO, however they did find that SIBO was twice as likely in GLP-1 users
US$ 24.09
US$ 24.52
US$ 29.64
